Company intelligence / Profile preview

Vyld

Berlin, Berlin, Germanyvyldness.de ↗

Ownership: Private
Development stage: Commercial

Overview

Vyld has developed the world's first tampon made from seaweed ("Kelpon"), which entered beta testing in 2023. The product aims to be radically sustainable—marine and land degradable—while being healthy and hypoallergenic. No clinical trial results are relevant as it’s a consumer device rather than a pharmaceutical or therapeutic.

Therapeutic areas: Women's Health
Modalities: Device (period products)Biomaterial (seaweed-based absorbent)
Industry: Consumable Medical Devices

Partnerships

Purpose Foundation/Safeguarding by Purpose Foundation holds golden share for steward ownership model

Beyond the preview

Go deeper on Vyld.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vyld.

Explore the full profile